REPL
Replimune Group, Inc. · Healthcare
CEO Sushil Patel sold $111K of Replimune Group, Inc.
Sold$111,300
$11.13Price
10,000Shares
−3%Stake
What REPL did after the filing
- The stock from Fri, Dec 5 open, $10.35
- −29.9%
- S&P 500, same days
- +0.8%
Measured over 30 trading days, to the Jan 21 close.
Traded Tue, Dec 2. Filed Thu, Dec 4, 4:30 PM ET, after the close. Returns use the Dec 5 open and the Jan 21 close. Not investment advice.